Kursgraf: Genmab-aktien har senest klaret sig godt et generelt svagt marked. Brud op gennem 200 dages glidende gennemsnit ...
Fra finanshuset ING – bearbejdet til dansk – læs hele analysen i original version her Den næste fase i handelsoptrapningen: ...
Fra Aktiesiden: Udskrevet/beregnet : 14/02-2025 17:00 CET Kun aktier, der har været handlet de seneste 10 børsdage, er medtaget. Navn Handlet Luk Gns.oms. 10dg +/-%...Læs mere » ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for...Læs mere » ...
Uddrag fra Statistica, Arctic Institute, Foreign Policy og Center for International and Strategic Studies Since the collapse of the Soviet Union, the Arctic has been considered a politically neutral ...
Ikke meget nyt om DRs kuldsejlede dokumentar om kryolitten på Grønland, og om regnestykket bag, hvad Danmark fik ud af det.
GN’s Remuneration Policy which was approved at the annual general meeting on March 13, 2024 and pursuant to which the ...
Uddrag fra Deutsche Bank og Zerohedge Here are the details, as BBG notes, the president signed a measure directing the US ...
“The impulse of bank lending to the private sector continued to recover in the Eurozone in Q4 2024 (1.5 after between 1.1 and ...
Henrik Ramlau-Hansen og Peter Løchte Jørgensen, henholdsvis tidl. adm. direktør i Danica Pension og professor ved Aarhus ...
Reuters Genmab increased operating profit more than expected in 2024 February 12, 2025 at 11:12 am EST Danish pharmaceutical ...
Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a...Læs mere » ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback